← HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
35
Jun 2026
Equity Holdings
₹2,538.96 Cr
Equity only, excl. debt & cash
Top 5 Weight
33.1%
Moderate
Top 10 Weight
54.1%
Moderate
Changes
35
4 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
70.2% of portfolio
📋 What Happened This Month HDFC Pharma and Healthcare Fund made 4 new additions and exited 1 stock this month. The biggest new buy was Ajanta Pharma Limited (Pharmaceuticals & Biotechnology) at 1.42% weight. Laurus Labs Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 3.17%. Among existing holdings, Sun Pharmaceutical Industries Limited saw the biggest increase — now at 9.96% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 7.16%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 70.2%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 70.1% 71.2% +1.1%
Healthcare Services 26.6% 26.9% +0.3%
Healthcare Equipment & Supplies 0.6% 0.6% +0.0%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 71.2% 70.2% -1.0%
Healthcare Services 26.9% 26.5% -0.4%
Healthcare Equipment & Supplies 0.6% 0.6% -0.1%
🟢
Biggest New Buy
Ajanta Pharma Limited
1.42% weight · Pharmaceuticals & Biotechnology
🔴
Biggest Exit
Laurus Labs Limited
3.17% was held · Pharmaceuticals & Biotechnology
Biggest Add
Sun Pharmaceutical Industries Limited
+0.76% · now 9.96%
Biggest Trim
Divi's Laboratories Limited
-0.86% · now 7.16%
🤝 Other funds also bought this month
Ajanta Pharma Limited 22 funds
Ajanta Pharma Limited
HDFC MNC Fund - Growth Option - Direct Plan
Kotak Dividend Yield Fund
Aditya Birla Sun Life Special Opportunities Fund-Direct-Growth + more
Dr. Reddy's Laboratories Limited 12 funds
Dr. Reddy's Laboratories Limited
ICICI Prudential Equity Minimum Variance Fund - Direct Plan - Growth
Groww Multi Asset Allocation Fund Direct Growth
Edelweiss Large & Mid Cap Fund - Direct Plan - Growth Option + more
Corona Remedies Limited 7 funds
Corona Remedies Limited
Invesco India Consumption Fund
Kotak Business Cycle - Direct Plan - Growth
Aditya Birla Sun Life ELSS Tax Saver Fund - Growth - Direct Plan + more
Jupiter Life Line Hospitals Ltd 1 fund
Jupiter Life Line Hospitals Ltd
Groww BSE Hospitals ETF FOF
👋 Other funds also exited
Laurus Labs Limited 7 funds
Laurus Labs Limited
DSP Healthcare Fund - Direct Plan - Growth
Navi Nifty Smallcap 250 Momentum quality index fund- Direct Plan
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF + more

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
🟢 4 New Entries 🔴 1 Exit ↑ 9 Increased ↓ 21 Decreased
#StockSectorWeight (Jun 2026)
1
Ajanta Pharma Limited
₹37.03 Cr
Pharmaceuticals & Biotechnology 1.42%
2
Corona Remedies Limited
₹34.10 Cr
Pharmaceuticals & Biotechnology 1.31%
3
Dr. Reddy's Laboratories Limited
₹27.14 Cr
Pharmaceuticals & Biotechnology 1.04%
4
Jupiter Life Line Hospitals Ltd
₹7.10 Cr
Healthcare Services 0.27%
#StockSectorLast Weight (May 2026)
1
Laurus Labs Limited
₹74.82 Cr
Pharmaceuticals & Biotechnology 3.17%
#StockSectorMay 2026Jun 2026Change
1
Sun Pharmaceutical Industries Limited
₹260.01 Cr
Pharmaceuticals & Biotechnology 9.20% 9.96% +0.76%
2
Rubicon Research Limited
₹44.50 Cr
Pharmaceuticals & Biotechnology 1.35% 1.70% +0.35%
3
Max Healthcare Institute Limited
₹145.53 Cr
Healthcare Services 5.26% 5.57% +0.31%
4
Cipla Limited
₹135.55 Cr
Pharmaceuticals & Biotechnology 4.92% 5.19% +0.27%
5
Shilpa Medicare Ltd
₹64.67 Cr
Pharmaceuticals & Biotechnology 2.28% 2.48% +0.20%
6
Acutaas Chemicals Ltd
₹119.54 Cr
Pharmaceuticals & Biotechnology 4.50% 4.58% +0.08%
7
Bajaj Healthcare Limited
₹19.99 Cr
Pharmaceuticals & Biotechnology 0.73% 0.77% +0.04%
8
IPCA Laboratories Limited
₹92.15 Cr
Pharmaceuticals & Biotechnology 3.50% 3.53% +0.03%
9
Gland Pharma Limited
₹31.24 Cr
Pharmaceuticals & Biotechnology 1.19% 1.20% +0.01%
#StockSectorMay 2026Jun 2026Change
1
Divi's Laboratories Limited
₹186.90 Cr
Pharmaceuticals & Biotechnology 8.02% 7.16% -0.86%
2
Glenmark Pharmaceuticals Limited
₹75.14 Cr
Pharmaceuticals & Biotechnology 3.28% 2.88% -0.40%
3
Alkem Laboratories Limited
₹104.43 Cr
Pharmaceuticals & Biotechnology 4.36% 4.00% -0.36%
4
Anthem Biosciences Limited
₹99.53 Cr
Pharmaceuticals & Biotechnology 4.15% 3.81% -0.34%
5
Wockhardt Limited
₹55.00 Cr
Pharmaceuticals & Biotechnology 2.44% 2.11% -0.33%
6
Metropolis Healthcare Limited
₹58.42 Cr
Healthcare Services 2.54% 2.24% -0.30%
7
Fortis Healthcare Limited
₹82.96 Cr
Healthcare Services 3.41% 3.18% -0.23%
8
Lupin Limited
₹137.47 Cr
Pharmaceuticals & Biotechnology 5.45% 5.26% -0.19%
9
Vijaya Diagnostic Centre Limited
₹66.02 Cr
Healthcare Services 2.70% 2.53% -0.17%
10
Zydus Lifesciences Limited
₹61.07 Cr
Pharmaceuticals & Biotechnology 2.50% 2.34% -0.16%

What Stocks Does This Fund Hold?

35 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹260.01 Cr
Pharmaceuticals & Biotechnology
9.96%
2
₹186.90 Cr
Pharmaceuticals & Biotechnology
7.16%
3
₹145.53 Cr
Healthcare Services
5.57%
4
₹137.47 Cr
Pharmaceuticals & Biotechnology
5.26%
5
₹135.55 Cr
Pharmaceuticals & Biotechnology
5.19%
6
₹131.87 Cr
Healthcare Services
5.05%
7
₹119.54 Cr
Pharmaceuticals & Biotechnology
4.58%
8
₹104.43 Cr
Pharmaceuticals & Biotechnology
4.00%
9
₹99.53 Cr
Pharmaceuticals & Biotechnology
3.81%
10
₹92.15 Cr
Pharmaceuticals & Biotechnology
3.53%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 HDFC Mutual Fund — Portfolio & Holdings
See all funds managed by HDFC Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.